Trial intelligence / Profile preview

Simvastatin in Acute Ischemic Stroke (STARS)

NCT01073007Phase 4Completed

Sponsor
Vall d'Hebron Research Institute
Start
Apr 2009
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in ischemic stroke comparing Simvastatin with Placebo (2 arms). Primary endpoint: Neurological and functional outcomes (mRS, NIHSS) at Month 3. Started Apr 2009; status: completed.

02

Drugs

simvastatin
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT01073007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01073007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call